跳转到主要内容
搜索

Conference: ASCPT 2026 Annual Meeting

日期: 2026 年 3 月 4 - 6 日

地点: Denver, CO

Innovator Sponsor

Certara is a proud Innovator Partner of this year’s 2026 ASCPT Annual Meeting

This partnership reflects our unwavering commitment to advancing clinical pharmacology, model-informed drug development, and regulatory science.

Join us at ASCPT 2026 as we showcase our scientific leadership through impactful presentations, posters, and abstracts spanning multiple therapeutic areas and disciplines. From cutting-edge research to real-world applications, discover how Certara’s experts are shaping the future of drug development.

Stay tuned for upcoming Certara insights and expertise showcased at this year’s annual meeting!

Where to hear Certara insights and expertise

Thursday, March 5, 9:15am-11:45am MST
Exceptional and Not the Exception: Innovation and Rigor in Maternal Pharmacotherapeutics Research

地点: Aurora Ballroom D

Chair: Rupsa C. Boelig, MD (she/her/hers) – Thomas Jefferson University
Chair: Edwin Lam, PharmD (he/him/his) – Biogen
主讲人:Jonathan Cherry, N/A (he/him/his) – March of Dimes
主讲人:Elimika Fletcher, PharmD, PhD (she/her/hers) – U.S. Food and Drug Administration
主讲人:Karen Rowland Yeo, PhD (she/her/hers) – Certara UK Ltd
主讲人:Ananth Kammala, PhD (he/him/his) – University of Texas Medical Branch
主讲人:Laura Bozzi, MS, PhD (she/her/hers) – Johnson & Johnson

Thursday, March 5, 12:15pm-1:15pm MST
Certara Learning Lab – Lunch & Learn
Equity by Design: Advancing Pharmacoequity Through Integrated Model-Informed Drug Development

How can we design drug development to deliver equitable outcomes from the start?

This 60-minute session introduces a Model-Informed Drug Development (MIDD) framework that integrates translational science, clinical pharmacology, and regulatory strategy to proactively advance pharmacoequity. Through real-world case examples, including maternal health and pediatrics, we demonstrate how PBPK, QSP, and exposure–response modeling can reduce uncertainty, support broader inclusion in Phase 3 trials, strengthen dose justification and labeling, and address evidence gaps in underrepresented populations.

Join our Certara experts to explore how integrated, quantitative strategies can transform development programs and accelerate equitable access to medicines for all patients.

Thursday, March 5, 1:15pm-3:30pm MST
Advancing Pharmacoequity in Pediatric Drug Development: Addressing Challenges and Innovating Solutions for Equitable Access

地点: Aurora Ballroom C

Chair: Antoinette Ajavon-Hartmann, PhD – Director, Clinical Pharmacology, Bristol Myers Squibb
Chair: Praneeth Jarugula, PharmD (he/him/his) – Associate Director, Clinical Pharmacology, Bristol Myers Squibb
主讲人:Tamorah Lewis, MD, PhD (she/her/hers) – Division Head, Pediatric Clinical Pharmacology & Toxicology, The Hospital for Sick Children
主讲人:Susan Abdel-Rahman, PharmD – Health Data Synthesis Institute
主讲人:Amy Cheung, PhD (she/her/hers) – Vice President, Certara

Thursday, March 5, 4:00pm-4:45pm MST
Featured Speaker – Eric Chun Yong Chan

地点: Aurora Ballroom A

Featured Speaker: Eric Chun Yong Chan, PhD (he/him/his) – National University of Singapore
Chair: Karen Rowland Yeo, PhD (she/her/hers) – Certara UK Ltd

Thursday, March 5, 7:00pm-9:00pm MST
Certara-Hosted Cocktail Reception

Please contact: [email protected] to request an invitation or for any questions.

Friday, March 6, 8:15am-9:00am MST
Featured Speaker - Rajesh Krishna

地点: Aurora Ballroom A

Featured Speaker: Rajesh Krishna, MBA, PhD – Certara
Chair: Sandra A.G Visser, PhD (she/her/hers) – Quantivis LLC, ASCPT President

Friday, March 6, 1:30pm-3:30pm MST
Pharmacoequity in Global Health: Advancing Equitable Access to Preventive Vaccines, Prophylactics, and Gene Therapies for All Populations

地点: Aurora Ballroom C

Chair: Amy Cheung, PhD (she/her/hers) – Vice President, Certara
Chair: Jeff S. Barrett, PhD (he/him/his) – Vice-President, Clinical Pharmacology & Quantitative Science, Genmab Pharmaceuticals
主讲人:Flora Musuamba, PhD – Federal Agency for Medicines and Health Products
主讲人:James WT Yates, BSc, PhD (he/him/his) – GSK
主讲人:Yu-Wei Lin, PhD (he/him/his) – Co-Director of MTCPG, University of Malaya, Adjunct Researcher, Monash University, Associate Director, Certara, Monash University
主讲人:Lionel Tan, MBBS. FRCP. PhD. DTM&H – Medicine Development Lead, Paediatric HIV, ViiV Healthcare
主讲人:Piet H. van der Graaf, PharmD, PhD – Senior Vice President and Professor of Systems Pharmacology, Certara

Friday, March 6, 1:30pm-5:30pm MST
Deciding Together: An Interactive Workshop on Integrating Evidence for Compatible Medicine Use During Lactation

地点: Crest 4

Chair: Xian Pan, PhD (she/her/hers) – Certara UK Ltd
Chair: Kristin Bigos, PhD – Johns Hopkins School of Medicine
主讲人:Andrew M. Novick, MD, PhD – University of Colorado
主讲人:Andrew S. Bulter, BSc, MSc, PhD (he/him/his) – Medicines and Healthcare products Regulatory Agency (MHRA)
主讲人:Jacqueline Gerhart, MBA, MS, PhD (she/her/hers) – Pfizer
主讲人:Lisa Almond, PhD (she/her/hers) – Certara UK
主讲人:Brian M. Cicali, MS, PhD – University of Florida

海报

Poster Session II: 2026 年 3 月 5 日, 星期四, 5-7pm
Poster #: PII-111
Understanding Post-Marketing Requirements and Commitments for CYP3A-Mediated Drug-Drug Interactions: An Analysis of FDA-Approved Drugs from 2015 to 2024

Presenting Author: Jingjing Yu

This poster was awarded a top poster ribbon.

Poster Session I: 2026 年 3 月 4 日, 星期三, 5-7pm
Poster #: PI-111
An Evidence-Based Approach for Managing DDI Risk for Patients in Clinical Trials

Presenting Author: Katie Owens

Poster Session II: 2026 年 3 月 5 日, 星期四, 5-7pm
Poster #: PII-110
Translating PD changes from healthy volunteers to phenylketonuria patients for MZE782 using a mechanistic PK PD model

Presenting Author: Bhabuk Koirala

This abstract was also selected for a 10-min oral presentation occurring 2026 年 3 月 5 日, 星期四, 4-5pm.

Poster Session II: 2026 年 3 月 5 日, 星期四, 5-7pm
Poster #: PII-109
Quantitative systems pharmacology model of a targeted radiotherapy to inform a target candidate profile and aid in early decision-making

Presenting Author: Sarah Minucci

Poster Session I: 2026 年 3 月 4 日, 星期三, 5-7pm
Poster #: PI-102
Identification and Integration of Available Systems Data to Develop a Virtual American Indian/Alaska Native Population

Presenting Authors: Lisa Almond and Laura Shireman

This poster was awarded a top poster ribbon.

Poster Session I: 2026 年 3 月 4 日, 星期三, 5-7pm
Poster #: LB-010
Investigating the Human Ocular Exposure of Ciprofloxacin via Oral and Intravenous Administration Using a Mechanistic Ocular PBPK Model

Presenting Authors: Bryan Holland

Poster Session II: 2026 年 3 月 5 日, 星期四, 5-7pm
Poster #: PII-084
Predicting Docetaxel-induced Neutropenia Using a Physiologically-based Pharmacokinetic/Pharmacodynamic Model

Presenting Authors: Mailys De Sousa Mendes

This poster was awarded a top poster ribbon.

Request a meeting with our experts


沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software